3.5000
+0.0720
+(2.10%)
At close: January 31 at 5:35:06 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-12,476.0000
-12,476.0000
-37,103.0000
-29,872.0000
-27,538.0000
Investing Cash Flow
-349.0000
-349.0000
138.0000
-242.0000
-112.0000
Financing Cash Flow
46,771.0000
46,771.0000
-5,651.0000
-5,180.0000
111,769.0000
End Cash Position
75,283.0000
75,283.0000
41,388.0000
83,921.0000
119,151.0000
Capital Expenditure
-337.0000
-337.0000
-93.0000
-233.0000
-107.0000
Issuance of Capital Stock
60,154.0000
60,154.0000
--
--
113,650.0000
Issuance of Debt
150.0000
150.0000
--
--
10,350.0000
Repayment of Debt
-3,765.0000
-3,765.0000
-4,735.0000
-3,742.0000
-1,178.0000
Free Cash Flow
-12,813.0000
-12,813.0000
-37,196.0000
-30,105.0000
-27,645.0000
12/31/2020 - 10/29/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GNFT.PA Genfit S.A.
3.5750
-2.85%
ADOC.PA Adocia SA
5.86
-0.34%
VLA.PA Valneva SE
2.7280
+10.89%
IPH.PA Innate Pharma S.A.
1.8000
+3.09%
ACTI.ST Active Biotech AB (publ)
0.1072
+1.13%
SIGHT.PA GenSight Biologics S.A.
0.3070
-1.92%
GNFT Genfit S.A.
3.7300
-4.60%
ABVX.PA ABIVAX Société Anonyme
6.04
+2.90%
DBV.PA DBV Technologies S.A.
0.8020
-1.11%
POXEL.PA Poxel S.A.
0.2855
-3.22%